| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |